Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse-Reference-Cited by-同舟云学术

Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse

Published:2002-02 Issue:2 Volume:173 Page:183-195
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Gordon Marcia N.,Holcomb Leigh A.,Jantzen Paul T.,DiCarlo Giovanni,Wilcock Donna,Boyett Kristal W.,Connor Karen,Melachrino Jason,O'Callaghan James P.,Morgan Dave

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference45 articles.

1. Inflammation and Alzheimer's disease;Akiyama;Neurobiol. Aging,2000

2. Progressive behavioral impairments in transgenic mice carrying both mutant APP and PS1 transgenes;Arendash;Brain Res.,2001

3. Functional phenotype in transgenic mice expressing mutant human presenilin-1;Barrow;Neurobiol. Dis.,2000

4. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease;Bennett;Neurobiol. Aging,1993

5. Evidence for glial-mediated inflammation in APPsw transgenic mice;Benzing;Neurobiol. Aging,1999

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease;Neurobiology of Disease;2024-10

2. Updates in Alzheimer's disease: from basic research to diagnosis and therapies;Translational Neurodegeneration;2024-09-04

3. Probing tau citrullination in Alzheimer’s disease brains and mouse models of tauopathy;2024-07-09

4. Induction of tauopathy in a mouse model of amyloidosis using intravenous administration of adeno‐associated virus vectors expressing human P301L tau;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-04

5. Pharmacological Inhibition of PLK2 Kinase Activity Mitigates Cognitive Decline But Aggravates APP Pathology in a Sex-Dependent Manner in APP/PS1 Mouse Model of Alzheimer's Disease;2024